WILLIAMS AND JENSEN, PLLC for MERCK & CO INC
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Trade (domestic/foreign) TRD
International trade issues and agreements. Monitor pending trade issues.
| Lobbyist | Covered position, as disclosed |
|---|---|
| CHRISTOPHER W HATCHER | — |
| KARINA LYNCH | — |
Taxation/Internal Revenue Code TAX
Issues related to corporate tax including international tax proposals. Tax application of the ACA Section 9008 to Orphan Drugs. H.R. 2029, Division Q.
| Lobbyist | Covered position, as disclosed |
|---|---|
| CHRISTOPHER W HATCHER | — |
| CHERYL LYNN JAEGER | — |
| KARINA LYNCH | — |
Health Issues HCR
21st Century Cures Initiative (House Energy and Commerce Committee) and Innovation for Healthier Americans (Senate HELP Committee); Drug safety; Congressional oversight issues; Implementation of Patient Protection and Affordable Care Act; Issues related to vaccines; and drug pricing issues; possible pharmaceutical provisions in the Continuing Resolution and the Consolidated Appropriations Act, 2016; H.R. 2029.
| Lobbyist | Covered position, as disclosed |
|---|---|
| SUSAN HIRSCHMANN | — |
| CHERYL LYNN JAEGER | — |
| KARINA LYNCH | — |
| ERIN BOOK MULLEN | — |
| GEORGE OLSEN | — |
Medicare/Medicaid MMM
Payment policies for prescription drugs. Rebates and co-pays for Medicare Part D.
| Lobbyist | Covered position, as disclosed |
|---|---|
| SUSAN HIRSCHMANN | — |
| MATTHEW B HOEKSTRA | — |
| CHERYL LYNN JAEGER | Shared employee, Ofc of the Speaker and Ofc of VA 7th; Sr Policy Advisor, Majority Leader, Rep. Eric Cantor; Sr. Advisor, Majority Whip, Rep Roy Blunt; Prof Staff House Committee on E&C; Sr LA to Rep. Christopher Cox |
| KARINA LYNCH | — |
| ERIN BOOK MULLEN | — |
| GEORGE OLSEN | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.